Emapalumab Effective in Rheumatologic Disease–Associated HLH

Emapalumab-containing regimens showed positive outcomes in patients with rheumatologic disease–associated hemophagocytic lymphohistiocytosis, a rare and life-threatening disorder.
Medscape Medical News

source https://www.medscape.com/viewarticle/emapalumab-effective-rheumatologic-disease-associated-2024a1000hgq?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost